This pan-Asian , @-week trial investigated efficacy and safety of IDegAsp vs biphasic insulin aspart @ ( BIAsp @ ) in Asian adults with type @ diabetes ( T@DM ) , inadequately controlled on once - or twice-daily ( BID ) basal , premixed or self-mixed insulin .